Search research articles
Contact Us
Filters
Showing results (211-220 of 344) with videos related to
Page
of 35
Sort By:
Cancer Science
|
October 7, 2016
Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G
Kohei Shitara, Kimio Yonesaka, Tadamichi Denda, et al.
Cancer Medicine
|
July 22, 2022
Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer
Hibiki Udagawa, Shunji Takahashi, Motohiro Hirao, et al.
Scientific Reports
|
September 25, 2023
p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab
Shota Fukuoka, Yoshikatsu Koga, Mayumi Yamauchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 15, 2025
A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901)
Tomohiro Kadota, Rika Fujii, Shohei Koyama, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
September 17, 2010
Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy
Kohei Shitara, Keitaro Matsuo, Seiji Ito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)
Akihito Kawazoe, Kota Itahashi, Noboru Yamamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 14, 2011
Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis
Kohei Shitara, Satoshi Morita, Kazumasa Fujitani, et al.
Cancer Immunology Research
|
November 27, 2024
The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment
Ayaka Tsuge, Sho Watanabe, Akihito Kawazoe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2021
A Low Tumor Mutational Burden and <i>PTEN</i> Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors
Keigo Chida, Akihito Kawazoe, Masahito Kawazu, et al.
The Lancet. Oncology
|
October 18, 2017
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
Toshihiko Doi, Kohei Shitara, Yoichi Naito, et al.
Page
of 35
Search research articles
Search
Showing results (211-220 of 344) with videos related to
Sort By:
Page
of 35
Cancer Science
|
October 7, 2016
Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G
Kohei Shitara, Kimio Yonesaka, Tadamichi Denda, et al.
Cancer Medicine
|
July 22, 2022
Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer
Hibiki Udagawa, Shunji Takahashi, Motohiro Hirao, et al.
Scientific Reports
|
September 25, 2023
p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab
Shota Fukuoka, Yoshikatsu Koga, Mayumi Yamauchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 15, 2025
A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901)
Tomohiro Kadota, Rika Fujii, Shohei Koyama, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
September 17, 2010
Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy
Kohei Shitara, Keitaro Matsuo, Seiji Ito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)
Akihito Kawazoe, Kota Itahashi, Noboru Yamamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 14, 2011
Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis
Kohei Shitara, Satoshi Morita, Kazumasa Fujitani, et al.
Cancer Immunology Research
|
November 27, 2024
The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment
Ayaka Tsuge, Sho Watanabe, Akihito Kawazoe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2021
A Low Tumor Mutational Burden and <i>PTEN</i> Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors
Keigo Chida, Akihito Kawazoe, Masahito Kawazu, et al.
The Lancet. Oncology
|
October 18, 2017
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
Toshihiko Doi, Kohei Shitara, Yoichi Naito, et al.
Page
of 35